Analysis of the rising incidence of thyroid cancer using the Surveillance, Epidemiology and End Results national cancer data registry DISCUSSION

被引:218
|
作者
Parangi, Sareh
Cramer, John D.
Prinz, Richard A.
Zeiger, Martha A.
Kebebew, Electron
机构
关键词
D O I
10.1016/j.surg.2010.10.016
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. The incidence of thyroid cancer has more than doubled in recent decades. Debate continues on whether the increasing incidence is a result of an increased detection of small neoplasms or other factors. Methods. Using the Surveillance, Epidemiology and End Results database, we examined the overall incidence of thyroid cancer with variations based on tumor pathology, size, and stage, as well as the current surgical and adjuvant therapy of thyroid carcinoma. Results. Thyroid cancer incidence increased 2.6-fold from 1973 to 2006. This change can be attributed primarily to an increase in papillary thyroid carcinoma, which increased 3.2-fold (P < .0001). The increase in papillary thyroid,carcinoma also was examined based on tumor size. Tumors 1 cm increased the most at a total of 441% between 1983 and 2006 or by 19.2% per yew; the incidence of papillary thyroid carcinoma also increased at 12.3%/year in 1.1-2-cm tumors, 10.3%/year in 2.1-5-cm tumors, and 12.0%/year for >5-cm tumors (all P < .0001 by Cochran-Armitage trend test). We also demonstrated a positive correlation between papillary thyroid carcinoma tumor size and stage of disease (Spearman, r = 0.285, P < .0001). Operative treatment for thyroid cancer also has shifted with total thyroidectomy replacing partial thyroidectomy as the most common surgical procedure. Conclusion. Contrary to other studies, our data indicate that the increasing incidence of thyroid cancer cannot be accounted for fully by an increased detection of small neoplasms. Other possible explanations for the increase in clinically significant (>1 cm) well-differentiated thyroid carcinomas should be explored. (Surgery 2010;148:1147-53.)
引用
收藏
页码:1152 / 1153
页数:2
相关论文
共 50 条
  • [21] Colorectal Cancer Incidence in the United States, 1999-2004 An Updated Analysis of Data From the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program
    Rim, Sun Hee
    Seeff, Laura
    Ahmed, Faruque
    King, Jessica B.
    Coughlin, Steven S.
    CANCER, 2009, 115 (09) : 1967 - 1976
  • [22] Biological difference of right versus left colon cancer: An analysis of the National Cancer Data Base and Surveillance, Epidemiology and End Results.
    Saha, Sukamal
    Berbiglia, Lindsay
    Shaik, Mohammed
    Gernand, Jill
    Saha, Supriya Kumar
    Hicks, Michael
    Arora, Madan L.
    Wiese, David
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [23] Incidence and mortality trends of metastatic prostate cancer: Surveillance, Epidemiology, and End Results database analysis
    Zhang, Aaron C.
    Rasul, Rehana
    Golden, Anne
    Feuerstein, Michael A.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2021, 15 (12): : E637 - E643
  • [24] Incidence and survival outcomes of secondary liver cancer: a Surveillance Epidemiology and End Results database analysis
    Wang, Zheng-Gang
    He, Zhi-Yi
    Chen, Yan-Yan
    Gao, Huan
    Du, Xing-Li
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (03) : 1273 - 1283
  • [25] OVARIAN-CANCER IN THE ELDERLY - AN ANALYSIS OF SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS PROGRAM DATA
    YANCIK, R
    RIES, LG
    YATES, JW
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1986, 154 (03) : 639 - 647
  • [26] Incidence of Second Malignancy in Patients with Papillary Thyroid Cancer from Surveillance, Epidemiology, and End Results 13 Dataset
    Endo, Mayumi
    Liu, Jessica B.
    Dougan, Marcelle
    Lee, Jennifer S.
    JOURNAL OF THYROID RESEARCH, 2018, 2018
  • [27] RACIAL AND ETHNIC DISPARITIES IN INCIDENCE AND MORTALITY FOR FIVE GASTROINTESTINAL CANCERS: RESULTS FROM THE SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS CANCER REGISTRY
    Bui, Aileen
    Yang, Liu
    Soroudi, Camille
    May, Folasade P.
    GASTROENTEROLOGY, 2021, 160 (06) : S60 - S60
  • [28] Cancer survival and incidence from the surveillance, epidemiology, and end results (SEER) program
    Ries, LAG
    Reichman, ME
    Lewis, DR
    Hankey, BF
    Edwards, BK
    ONCOLOGIST, 2003, 8 (06): : 541 - 552
  • [29] Neoadjuvant Versus Adjuvant Treatment of Gastroesophageal Junction Cancer: An Analysis of Data from the Surveillance, Epidemiology, and End Results (SEER) Registry
    Miccio, J. A.
    Oladeru, O. T.
    Xue, Y.
    Yang, J.
    Yoon, H.
    Ryu, S.
    Stessin, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E120 - E120
  • [30] Clinicopathological Characteristics and Outcomes of Gliosarcoma: Analysis using the Surveillance, Epidemiology, and End Results (SEER) Registry Data
    Yu, H. M.
    Tsai, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S244 - S244